DaubesUP, and all we need from "K" is POC, which will come very,very,soon with BP partnership to follow.
"I don't think you understand "K"s MOA...or ATLEAST the moa that BP is hoping to see in this phase 2 trial. Oncology drugs are the big ticket drugs for BP. If K pans out in this trial I can easily see a collaboration because we need help exploring the MANY cancer types that K can have a positive effect on. No to mention exploring combo trials."
Repeat: BP has designed this phase 2 trial.
I have no clue what will happen or which drug may fall first into BPs hand. I am confident we partner soon